KPRX — Kiora Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $13.37m
- -$17.91m
- 61
- 99
- 69
- 90
Annual cashflow statement for Kiora Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K/A | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.1 | -8.09 | -13.8 | -13.6 | -12.5 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 1.51 | 1.05 | 4.28 | 2.56 | 4.64 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.72 | -0.321 | -1.04 | 0.669 | -1.82 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -8.15 | -7.32 | -10.7 | -10.4 | -9.56 |
| Capital Expenditures | 0 | -0.02 | -0.064 | 0 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -0.224 | -0.093 | 0.006 | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 0 | -0.244 | -0.157 | 0.006 | 0 |
| Financing Cash Flow Items | -0.003 | -0.499 | -1 | -0.016 | -0.053 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.92 | 5 | 17.6 | 8.62 | 5.97 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.23 | -2.59 | 6.67 | -1.89 | -3.55 |